New CD56 positive and cytotoxic T-cell cutaneous lymphomas from the World Health Organisation

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 385-387

  Slater, D N ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD5 ANTIGEN; CD56 ANTIBODY; CD56 ANTIGEN; CYTOTOXIC FACTOR; GRANZYME B; PERFORIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BLASTIC NATURAL KILLER CELL LYMPHOMA; CANCER CHEMOTHERAPY; CD 56 POSITIVE CUTANEOUS LYMPHOMA; CELL GRANULE; CELLULAR DISTRIBUTION; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; EDITORIAL; EPSTEIN BARR VIRUS; EXTRANODAL NATURAL KILLER T CELL LYMPHOMA; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MULTIDRUG RESISTANCE; NASAL TYPE LYMPHOMA; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SERODIAGNOSIS; SKIN CANCER; SKIN LYMPHOMA; SUBCUTANEOUS PANNICULITIS LIKE T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

ANTIGENS, CD56; HUMANS; KILLER CELLS; LYMPHOMA, T-CELL, CUTANEOUS; PANNICULITIS; PHENOTYPE; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TERMINOLOGY;

EID: 0037365755     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05340.x     Document Type: Editorial

References (13)

1. Slater DN. The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective. Br J Dermatol 2002; 147: 633-9.
2. Child FJ, Mitchell TJ, Whittaker SJ et al. Blastic natural killer (NK)-cell and extranodal NK-like T-cell lymphoma presenting in the skin: a report of six cases from the UK. Br J Dermatol, 2003; 148: 507-15.
3. Hoque SR, Child FJ, Whittaker SJ et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148: 516-25.
4. Savoia PS, Fierro MT, Novelli M et al. CD56 positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 1997; 137: 966-71.
5. Slater DN. Cutaneous CD56 natural killer and natural killer-like T-cell lymphoma. Br J Dermatol 2000; 142: 853-6.
6. Salhany KE, Macon WR, Choi JK et al. Subcutaneous panniculitis-like T-cell lymphoma. Clinicopathologic, immunophenotypic and genotypic analysis of alpha/beta and gamma/delta subtype. Am J Surg Pathol 1998; 22: 881-93.
7. Sander CA, Flaig MJ, Jaffe ES. Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. Clin Lymphoma 2001; 2: 86-100.
8. Alizadeh AA, Elsen MB, Davis ER. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
9. Jang KA, Choi JH, Sung KJ et al. Primary CD56 nasal-type T/natural killer-cell subcutaneous panniculitic lymphoma: presentation as haemophagocytic syndrome. Br J Dermatol 1999; 141: 706-9.
10. Chang SE, Huh J, Choi JH et al. Clinicopathological features of nasal type T/NK-cell lymphomas with lobular panniculitis. Br J Dermatol 2000; 142: 924-30.
11. Miyamato T, Yoshino T, Takehisa T et al. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological finding of four cases. Br J Dermatol 1998; 139: 481-7.
12. Yoon TY, Lee HT, Chang SH. Nasal-type T/natural killer cell angiocentric lymphoma, Epstein-Barr-associated virus and showing clonal T-cell receptor gamma gene rearrangement. Br J Dermatol 1999; 140: 505-8.
13. Petrella T, Dalac S, Maynadie M et al. CD4 and CD56 positive cutaneous neoplasms: a distinct haematological entity? Am J Surg Path 1999; 23: 137-46.